Alan Au is the Founder and Managing Partner of GT Healthcare Capital Partners. See sector focus and contact routes.
Alan Au is the Founder and Managing Partner of GT Healthcare Capital Partners, a venture capital firm he established in September 2015 with over 20 years of experience in healthcare investment banking and private equity across Asia and China. His investment thesis targets early-stage healthcare technology companies, focusing on medical devices, pharmaceuticals, and artificial intelligence applications in drug discovery within Asia and Greater China. The firm has executed 22 investments, including a Series C round in Autobahn Therapeutics in July 2024, though specific check sizes and lead/follow behavior are not publicly detailed. Notable portfolio companies include Oxford Nanopore, I-Mab Biopharma Group (where Au serves as a Board member), CSPC Pharmaceutical Group (where he is Audit Committee Chairman), and RefleXion Medical. Au holds a Board seat at I-Mab and CSPC, and serves as a panel member for the Hong Kong SAR Government’s Innovation and Technology Fund, reflecting his active governance role beyond capital deployment. While the firm frequently collaborates with Oxford Sciences Innovation to invest in Oxford University spin-outs, no distinctive public
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Shanghai.
Investors like Alan Au · Full investor directory · Investor access · Company funding database